Discovery of kidney cancer driver could lead to new treatment strategy
Thursday, July 19, 2018 - 14:40
in Health & Medicine
Researchers suggest that ZHX2 is a potential new therapeutic target for clear cell renal cell carcinoma, which is the most common type of kidney cancer.